Anti-Endotoxin Monoclonal Antibodies
- 23 April 1992
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 326 (17) , 1153-1157
- https://doi.org/10.1056/nejm199204233261711
Abstract
Several monoclonal antibodies directed against bacterial lipopolysaccharide (endotoxin) are being developed for the adjunctive treatment of gram-negative sepsis. Two of these, E5 (XOMA, Berkeley, Calif.)1 and HA-1A (Centocor, Malvern, Pa.),2 have been studied in clinical trials and evaluated by the Food and Drug Administration for use in the United States. An open advisory-committee meeting was held by the FDA on September 4, 1991, at which new information was presented about the preclinical and clinical studies of these two products.3 This article discusses some of the issues relating to the development and evaluation of these agents in the context of this . . .Keywords
This publication has 16 references indexed in Scilit:
- Short-Rerm Mortality Predictions for Critically Ill Hospitalized Adults: Science and EthicsScience, 1991
- Use of Immunoglobulins in Prevention and Treatment of Infection in Critically III Patients: Review and CritiqueClinical Infectious Diseases, 1991
- A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study GroupPublished by American Medical Association (AMA) ,1991
- Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against EndotoxinNew England Journal of Medicine, 1991
- Studies of an Antiendotoxin Antibody in Preventing the Physiologic Changes of Endotoxemia in Awake SheepAmerican Review of Respiratory Disease, 1990
- Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies.The Journal of Experimental Medicine, 1990
- Effects of Anti-Lipid a Human Monoclonal Antibody on Lipopolysaccharide-Induced Toxicity to the KidneyJournal of Urology, 1989
- APACHE IICritical Care Medicine, 1985
- Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies.Proceedings of the National Academy of Sciences, 1985
- Steroids in the Treatment of Clinical Septic ShockAnnals of Surgery, 1976